APP and Alzheimer disease: Studies have reported that Aβ42 is reduced in patients’ CSF [62], and it can be understood that Aβ in the AD group is due to the damage of the blood brain barrier, which leads to the loss of neurons that produce APP, and the accumulation of Aβ in the brain and the reduction of Aβ clearance.